Predictive value of routine point-of-care cardiac troponin T measurement for prehospital diagnosis and risk-stratification in patients with suspected acute myocardial infarction

Abstract

Objective:

The purpose of this study was to determine the predictive value of routine prehospital point-of-care cardiac troponin T measurement for diagnosis and risk stratification of patients with suspected acute myocardial infarction.

Methods and results:

All prehospital emergency medical service vehicles in the Central Denmark Region were equipped with a point-of-care cardiac troponin T device (Roche Cobas h232) for routine use in all patients with a suspected acute myocardial infarction. During the study period, 1 June 2012–30 November 2015, prehospital point-of-care cardiac troponin T measurements were performed in a total of 19,615 cases seen by the emergency medical service and 18,712 point-of-care cardiac troponin T measurements in 15,781 individuals were matched with an admission. A final diagnosis of acute myocardial infarction was confirmed in 2187 cases and a total of 2150 point-of-care cardiac troponin T measurements (11.0%) had a value ≥50 ng/l, including 966 with acute myocardial infarction (sensitivity: 44.2%, specificity: 92.8%). Patients presenting with a prehospital point-of-care cardiac troponin T value ≥50 ng/l had a one-year mortality of 24% compared with 4.8% in those with values <50 ng/l, log-rank: p<0.001. The following variables showed the strongest association with mortality in multivariable analysis: point-of-care cardiac troponin T≥50 ng/l (hazard ratio 2.10, 95% confidence interval: 1.90–2.33), congestive heart failure (hazard ratio 1.93, 95% confidence interval: 1.74–2.14), diabetes mellitus (hazard ratio 1.42, 95% confidence interval: 1.27–1.59) and age, one-year increase (hazard ratio 1.08, 95% confidence interval: 1.08–1.09).

Conclusions:

Patients with suspected acute myocardial infarction and a prehospital point-of-care cardiac troponin T ≥50 ng/l have a poor prognosis irrespective of the final diagnosis. Routine troponin measurement in the prehospital setting has a high predictive value and can be used to identify high-risk patients even before hospital arrival so that they may be re-routed directly for advanced care at an invasive centre.

Keywords

Acute myocardial infarction prehospital triage/methods cardiac troponin emergency medical services point-of-care

Get full access to this article

View all access options for this article.

References

Terkelsen

Sorensen

Maeng

et al . System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 2010; 304: 763–771.

Terkelsen

Jensen

Tilsted

et al . Health care system delay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data. Ann Intern Med 2011; 155: 361–367.

Terkelsen

Jensen

Tilsted

et al . Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarction. Circ Cardiovasc Interv 2011; 4: 570–576.

Cannon

Lin

Lytle

et al . Use of prehospital 12-lead electrocardiography and treatment times among ST-elevation myocardial infarction patients with atypical symptoms. Acad Emerg Med 2014; 21: 892–898.

Brady

Roberts

Morris

. The nondiagnostic ECG in the chest pain patient: Normal and nonspecific initial ECG presentations of acute MI. Am J Emerg Med 1999; 17: 394–397.

Stengaard

Sorensen

Rasmussen

et al . Acute versus subacute angiography in patients with non-ST-elevation myocardial infarction – the NONSTEMI trial phase I. Eur Heart J Acute Cardiovasc Care 2016 ; 6(6):490–499.

Sorensen

Terkelsen

Steengaard

et al . Prehospital troponin T testing in the diagnosis and triage of patients with suspected acute myocardial infarction. Am J Cardiol 2011; 107: 1436–1440.

Stengaard

Sorensen

Ladefoged

et al . Quantitative point-of-care troponin T measurement for diagnosis and prognosis in patients with a suspected acute myocardial infarction. Am J Cardiol 2013; 112: 1361–1366.

Pedersen

. The Danish Civil Registration System. Scand J Public Health. 2011; 39: 22–25.

10.

Schmidt

Sandegaard

et al . The Danish National Patient Registry: A review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449–490.

11.

Lynge

Sandegaard

Rebolj

. The Danish National Patient Register. Scand J Public Health 2011; 39: 30–33.

12.

Grann

Erichsen

Nielsen

et al . Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol 2011; 3: 133–138.

13.

Schmidt

Maeng

Jakobsen

et al . Existing data sources for clinical epidemiology: The Western Denmark Heart Registry. Clin Epidemiol 2010; 2: 137–144.

14.

Thygesen

Alpert

White

et al . Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551–2567.

15.

Roth

Malov

Golovner

et al . The ‘SHAHAL’ experience in Israel for improving diagnosis of acute coronary syndromes in the prehospital setting. Am J Cardiol 2001; 88: 608–610.

16.

Svensson

Axelsson

Nordlander

et al . Prognostic value of biochemical markers, 12-lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome. J Intern Med 2004; 255: 469–477.

17.

Gust

Bottiger

et al . Bedside troponin T testing is not useful for early out-of-hospital diagnosis of myocardial infarction. Acta Anaesthesiol Scand 1998; 42: 414–417.

18.

Ezekowitz

Welsh

Weiss

et al . Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT-4). J Am Heart Assoc 2015; 4(12).

19.

Roffi

Patrono

Collet

et al . 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267–315.

20.

Sandoval

Thygesen

. Myocardial infarction type 2 and myocardial injury. Clin Chem 2017; 63: 101–107.

21.

Sarkisian

Saaby

Poulsen

et al . Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med 2016; 129: 446.e5–e21.

22.

Bruins Slot

van der Heijden

et al . Point-of-care tests in suspected acute myocardial infarction: A systematic review. Int J Cardiol 2013; 168: 5355–5362.

23.

Stengaard

Sorensen

Rasmussen

et al . Prehospital diagnosis of patients with acute myocardial infarction. Diagnosis 2016; 3: 155–166.

24.

Sundboll

Adelborg

Munch

et al . Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: A validation study. BMJ Open 2016; 6: e012832.

25.

Stengaard

Sorensen

Ladefoged

et al . The potential of optimizing prehospital triage of patients with suspected acute myocardial infarction using high-sensitivity cardiac troponin T and copeptin. Biomarkers 2016: 1–13.

26.

Cimon

Weeks

et al . CADTH optimal use reports. Point-of-care troponin testing in patients with symptoms suggestive of acute coronary syndrome: A health technology assessment. Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health, 2016.